Your browser doesn't support javascript.
loading
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam).
Feldman, Howard H; Luchsinger, José A; Léger, Gabriel C; Taylor, Curtis; Jacobs, Diane M; Salmon, David P; Edland, Steven D; Messer, Karen; Revta, Carolyn; Flowers, Sarah A; Jones, Kerry S; Koulman, Albert; Yarasheski, Kevin E; Verghese, Philip B; Venkatesh, Venky; Zetterberg, Henrik; Durant, January; Lupo, Jody-Lynn; Gibson, Gary E.
Affiliation
  • Feldman HH; Department of Neurosciences, University of California San Diego, La Jolla, California, United States of America.
  • Luchsinger JA; Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, California, United States of America.
  • Léger GC; Shiley-Marcos Alzheimer's Disease Research Center, La Jolla, California, United States of America.
  • Taylor C; Columbia University Irving Medical Center, New York, New York, United States of America.
  • Jacobs DM; Department of Neurosciences, University of California San Diego, La Jolla, California, United States of America.
  • Salmon DP; Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, California, United States of America.
  • Edland SD; Department of Neurosciences, University of California San Diego, La Jolla, California, United States of America.
  • Messer K; Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, California, United States of America.
  • Revta C; Department of Neurosciences, University of California San Diego, La Jolla, California, United States of America.
  • Flowers SA; Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, California, United States of America.
  • Jones KS; Shiley-Marcos Alzheimer's Disease Research Center, La Jolla, California, United States of America.
  • Koulman A; Department of Neurosciences, University of California San Diego, La Jolla, California, United States of America.
  • Yarasheski KE; Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, California, United States of America.
  • Verghese PB; Shiley-Marcos Alzheimer's Disease Research Center, La Jolla, California, United States of America.
  • Venkatesh V; Department of Neurosciences, University of California San Diego, La Jolla, California, United States of America.
  • Zetterberg H; Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, California, United States of America.
  • Durant J; Shiley-Marcos Alzheimer's Disease Research Center, La Jolla, California, United States of America.
  • Lupo JL; Department of Neurosciences, University of California San Diego, La Jolla, California, United States of America.
  • Gibson GE; Alzheimer's Disease Cooperative Study, University of California San Diego, La Jolla, California, United States of America.
PLoS One ; 19(5): e0302998, 2024.
Article in En | MEDLINE | ID: mdl-38809849

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiamine / Alzheimer Disease Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiamine / Alzheimer Disease Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos